TISSUE PROCUREMENT FACILITY SHARED RESOURCE The Tissue Procurement Facility (TPF) is the main conduit for access to protocol driven tissue-based research. As part of the 2019 strategic plan, this SR was expanded and reorganized to provide additional services and with a more robust pipeline for faculty conducting this type of clinical research. The expansion of this resource led to enhanced services including: ? More timely fresh tissue collection. TPF has developed a pipeline to collect fresh tissue for next-generation research focusing on single-cell and chip sequencing. The fresh tissue infrastructure requires significant collaboration between Surgical Pathology, Anatomic Pathology, TPF, and Clinical Protocol and Data Management (CPDM). For scRNA sequencing TPF has added an additional workflow to facilitate this methodology. ? Tissue dissociation. TPF is equipped for single-cell dissociation to process tissue to single-cell for investigators that do not have the technology to do so and/or are investigating more robust experiments. ? Ultrapure plasma processing. Ultra highspeed plasma purification for downstream cfDNA analysis. Ultrapure plasma will produce a significantly cleaner signal-to-noise ratio for investigators looking at cfDNA. TPFis led by an experienced faculty and staff. Dr. Calhoun is Director of Surgical Pathology and Anatomical Pathology at UNC and serves as Pathology Director. He works closely with the surgical liaison, co-leader HJ Kim to ensure responsible policies are in place for the procurement of research specimens following guidelines established by the UNC Hospitals. Amy Garratt serves as the Facility Director for the SR and its translational consenting and collection component. This is a well-managed resource with an operating budget of $1.0M. TPF requests $229,718 (21% of the total) for fiscal year 2020. LCCC members were more than 66% of the users in fiscal year 2019, virtually all other users were performing cancer research. The Facility procured, and distributed 46,091 specimens to support 154 different investigator-initiated studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016086-45
Application #
10089838
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
1997-06-01
Project End
2025-11-30
Budget Start
2020-12-01
Budget End
2021-11-30
Support Year
45
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Lianga, Noel; Doré, Carole; Kennedy, Erin K et al. (2018) Cdk1 phosphorylation of Esp1/Separase functions with PP2A and Slk19 to regulate pericentric Cohesin and anaphase onset. PLoS Genet 14:e1007029
Allott, Emma H; Geradts, Joseph; Cohen, Stephanie M et al. (2018) Frequency of breast cancer subtypes among African American women in the AMBER consortium. Breast Cancer Res 20:12
Dhungel, Bal Mukunda; Montgomery, Nathan D; Painschab, Matthew S et al. (2018) 'Discovering' primary effusion lymphoma in Malawi. AIDS 32:2264-2266
Cameron, Jennifer E; Rositch, Anne F; Vielot, Nadja A et al. (2018) Epstein-Barr Virus, High-Risk Human Papillomavirus and Abnormal Cervical Cytology in a Prospective Cohort of African Female Sex Workers. Sex Transm Dis 45:666-672
Lim, Joseph K; Liapakis, Ann Marie; Shiffman, Mitchell L et al. (2018) Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis. Clin Gastroenterol Hepatol 16:1811-1819.e4
Wang, Gary P; Terrault, Norah; Reeves, Jacqueline D et al. (2018) Prevalence and impact of baseline resistance-associated substitutions on the efficacy of ledipasvir/sofosbuvir or simeprevir/sofosbuvir against GT1 HCV infection. Sci Rep 8:3199
Phillips, Bonnie; Van Rompay, Koen K A; Rodriguez-Nieves, Jennifer et al. (2018) Adjuvant-Dependent Enhancement of HIV Env-Specific Antibody Responses in Infant Rhesus Macaques. J Virol 92:
Takaku, Motoki; Grimm, Sara A; Roberts, John D et al. (2018) GATA3 zinc finger 2 mutations reprogram the breast cancer transcriptional network. Nat Commun 9:1059
Galanis, Evanthia; Anderson, S Keith; Miller, C Ryan et al. (2018) Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02. Neuro Oncol 20:546-556
Agle, Kimberle; Vincent, Benjamin G; Piper, Clint et al. (2018) Bim regulates the survival and suppressive capability of CD8+ FOXP3+ regulatory T cells during murine GVHD. Blood 132:435-447

Showing the most recent 10 out of 1525 publications